Chimeric Therapeutics LimitedASX: CHM

First patient enrolled in CHM CDH17 Phase 1/2 clinical trial

Jul 22, 2024 at 4:33 AM UTC · Issued by Chimeric Therapeutics Limited

Chimeric Therapeutics Ltd has released a press release.

View Attachment